Based on my analysis, here's my assessment:

• The National Design Studio (NDS), led by Chief Design Officer Joe Gebbia, was indeed involved in designing the TrumpRx.gov platform, which launched in February 2026¹.
• President Trump claimed in May 2026 that TrumpRx "has saved Americans more than $400 million already"².
• However, this $400 million figure is an unverified administration claim with no independent audit or verification².
• Critics note that many of the "discounts" on TrumpRx were already available through existing manufacturer patient assistance programs and coupon platforms—meaning the actual new savings may be substantially lower³.
• The platform is restricted to cash-paying patients who forgo insurance, limiting its reach to roughly 8% of Americans (the uninsured population), since insured patients would lose progress toward deductibles by paying cash³.
• By May 2026 (approximately 3-4 months after launch), the "few months" timeframe is accurate, but the $400,000,000 savings figure should be treated as a self-reported estimate rather than an independently confirmed fact².
• Some drugs advertised with steep discounts feature temporary introductory pricing that expires after one or two fills, further complicating the true savings calculation³.

Overall validity: 45%

1. Remarks on Announcing the TrumpRX Prescription Drug Website and an Exchange With Reporters | The American Presidency Project
2. White House adds generic drugs to direct-to-consumer TrumpRx site
3. Updated: TrumpRx Discounts 0.13 Percent of Prescription Drugs ...